<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-0OTM2B1E</identifier><date>2016</date><creator>Štrukelj, Borut</creator><relation>documents/doc/0/URN_NBN_SI_doc-0OTM2B1E_001.pdf</relation><relation>documents/doc/0/URN_NBN_SI_doc-0OTM2B1E_001.txt</relation><format format_type="issue">2/3</format><format format_type="volume">67</format><format format_type="type">article</format><format format_type="extent">str. 69-73</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">4081009</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-0OTM2B1E</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">distonija</subject><subject language_type_id="slv">Epilepsija</subject><subject language_type_id="slv">fibromialgija</subject><subject language_type_id="slv">kaheksija</subject><subject language_type_id="slv">kanabinoidi</subject><subject language_type_id="slv">multipla skleroza</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Potencialni učinki kanabinoidov</title><title>Potential effects of cannabinoids</title></Record>